Metabolic
Metabolic
Tirzepatide
GIP / GLP-1 dual receptor agonist
Tirzepatide is a dual agonist built on the GIP backbone with GLP-1 activity and a fatty-diacid chain for week-long action. Alongside semaglutide, it defines the current era of incretin-based metabolic research.
Studied in
Incretin researchGlycemic controlWeight management
$48.00
Ships tracked within 1–3 business days · Certificate of analysis on request · Ask us about this product
Not evaluated by the FDA · Not intended to diagnose, treat, cure, or prevent any disease
Handling. Keep lyophilized vials cool, dry, and away from light. Refrigerate or freeze for long-term storage, and refrigerate after reconstitution. See the storage guide.
